Biostate AI has launched K-Dense Beta, a multi-agent AI system designed to compress biological research cycles from years to days. The system coordinates specialized agents to plan experiments, review literature, design analyses, execute code in secure sandboxes, and generate publication-ready reports, while cross-checking references to reduce errors. K-Dense Beta also tracks every decision and action to create full traceability and auditability, aiming to overcome limitations seen in other generative AI models.

K-Dense Beta was validated in collaboration with Harvard Medical School’s aging research team. Tasked with building a transcriptomic aging clock, the AI analysed more than 600,000 transcriptomic profiles, selecting 60,000 high-quality samples and strategically focusing on 5,000 genes. The analysis revealed that different sets of RNA transcripts serve as predictors of biological age at different stages of life, highlighting aging as a sequence of biological programs rather than a uniform process.

“K-Dense enabled us to complete an entire research study in just a few weeks, work that typically requires months or years of expert analysis,” said Professor David Sinclair, Co-Director of the Paul F. Glenn Center for Biology of Aging Research. “It pointed us to markers and pathways that warrant deeper study and helped us build a unified AI model for predicting biological age. Importantly, it also provided a measure of how reliable those predictions are, which is critical for scientific applications and has not been available in prior AI approaches.”

The system integrates with standard bioinformatics pipelines, tools such as AlphaFold, curated databases, and multiple specialized large language models. K-Dense Beta achieved 29.2% accuracy on BixBench, a leading bioinformatics benchmark, surpassing other frontier models including GPT-5 (22.9%), GPT-4o (18%), and Claude 3.5 Sonnet (18%).

Biostate AI is now validating K-Dense Beta with academic institutions, biotechnology startups, and major pharmaceutical companies worldwide. Built on Google Cloud’s Gemini 2.5 Pro, the system aims to accelerate scientific discovery while maintaining rigorous standards. The Harvard Medical School findings have been submitted for peer review and are available as a bioRxiv preprint.

K-Dense Beta is currently available to select design partners, with broader access planned later in 2025. Biostate AI said the system represents a step toward a new model of research where AI not only supports but actively drives complex scientific workflows.